CROSSBOW Trademark

Trademark Overview


On Friday, October 22, 2021, a trademark application was filed for CROSSBOW with the United States Patent and Trademark Office. The USPTO has given the CROSSBOW trademark a serial number of 97087361. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by Crossbow Therapeutics, Inc.. The CROSSBOW trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, ...
crossbow

General Information


Serial Number97087361
Word MarkCROSSBOW
Filing DateFriday, October 22, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, antivirals
Pseudo MarkCROSS BOW

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCrossbow Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameCrossbow Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, October 26, 2021NEW APPLICATION ENTERED
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 1, 2022ASSIGNED TO EXAMINER
Monday, August 8, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 8, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 8, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, August 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 8, 2023SOU EXTENSION 1 FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 25, 2023TEAS PETITION TO REVIVE RECEIVED
Sunday, June 25, 2023PETITION TO REVIVE-GRANTED
Sunday, June 25, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 26, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 11, 2023SOU EXTENSION 2 FILED
Monday, September 11, 2023SOU EXTENSION 2 GRANTED
Monday, March 4, 2024SOU EXTENSION 3 FILED
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 4, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 4 FILED
Wednesday, September 4, 2024SOU EXTENSION 4 GRANTED